UT Health San Antonio, University Hospital Begin Second Phase of Clinical Trial for Promising COVID-19 Drug
May 14, 2020
May 14, 2020
SAN ANTONIO, Texas, May 14 -- The University of Texas Health Science Center at San Antonio issued the following news release:
The COVID-19 Infectious Disease team at UT Health San Antonio and University Health System is beginning the second stage of the remdesivir clinical trial, which is being sponsored by the National Institute of Allergy and Infectious Diseases, NIAID.
This second phase of the trial follows encouraging results from the initial part of the study which . . .
The COVID-19 Infectious Disease team at UT Health San Antonio and University Health System is beginning the second stage of the remdesivir clinical trial, which is being sponsored by the National Institute of Allergy and Infectious Diseases, NIAID.
This second phase of the trial follows encouraging results from the initial part of the study which . . .